Protein Based Vaccines

Protein based subunit antibodies exhibit an antigen to the safe framework without viral particles, utilizing a particular, confined protein of the pathogen.

Acellular pertussis (AP) antibodies contain inactivated pertussis poison (protein) and may contain at least one other bacterial parts.

Hepatitis B immunizations are made out of the hepatitis B infection surface antigen (HbsAg), a protein created by hepatitis B infection. Prior immunization items were created utilizing purged plasma of tainted people. This creation technique has been supplanted by recombinant innovation that can deliver HbsAg without requiring human plasma expanding the security of the immunization by barring the hazard from potential tainting of human plasma.

  • Contraindications - Vaccines, vaccination
  • New approaches to combat bacterial pathogens
  • Public health concerns in vaccination
  • Vaccine resistance and need of Next-Gen Conjugate Vaccines
  • Vaccines formulation and technologies used in conjugated vaccines

Related Conference of Protein Based Vaccines

July 27-28, 2018

31st Annual Congress on Vaccines & Clinical Trials

Vancouver, Canada
Aug 27-29, 2018

Annual Congress and Expo on Vaccines & Immunology

Amsterdam, Netherlands
October 22-23, 2018

30th World Congress on Vaccines and Immunization

Osaka, Japan

Protein Based Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in